Erwinase For Injection - Shortage And Replacement With UK Labelled Stock

Erwinase for Injection Recall Summary Erwinase for Injection, a medication used in cancer treatment, is being replaced with stock that is labeled according to UK standards rather than Canadian labeling requirements. This change affects patients and healthcare providers across Canada who use this drug. The replacement stock may have different label formatting and information presentation than what Canadian users are accustomed to, though the medication itself remains the same.

Category

drug recall

Country

Canada

Agency

HC-DRUGS

Recall date

2016-09-16

Status

Closed

Distribution

Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/b8241f68-3908-4b27-acd4-19ff0e021f24